Skip to main content
Oxford University Press - PMC COVID-19 Collection logoLink to Oxford University Press - PMC COVID-19 Collection
. 2020 Apr 30;107(10):1250–1261. doi: 10.1002/bjs.11670

Immediate and long-term impact of the COVID-19 pandemic on delivery of surgical services

K Søreide 1,2,, J Hallet 5, J B Matthews 7, A A Schnitzbauer 11, P D Line 3,4, P B S Lai 12, J Otero 13, D Callegaro 14, S G Warner 8, N N Baxter 16, C S C Teh 17,18,19, J Ng-Kamstra 6, J G Meara 9,10, L Hagander 20, L Lorenzon 15
PMCID: PMC7267363  PMID: 32350857

Abstract

Background

The ongoing pandemic is having a collateral health effect on delivery of surgical care to millions of patients. Very little is known about pandemic management and effects on other services, including delivery of surgery.

Methods

This was a scoping review of all available literature pertaining to COVID-19 and surgery, using electronic databases, society websites, webinars and preprint repositories.

Results

Several perioperative guidelines have been issued within a short time. Many suggestions are contradictory and based on anecdotal data at best. As regions with the highest volume of operations per capita are being hit, an unprecedented number of operations are being cancelled or deferred. No major stakeholder seems to have considered how a pandemic deprives patients with a surgical condition of resources, with patients disproportionally affected owing to the nature of treatment (use of anaesthesia, operating rooms, protective equipment, physical invasion and need for perioperative care). No recommendations exist regarding how to reopen surgical delivery. The postpandemic evaluation and future planning should involve surgical services as an essential part to maintain appropriate surgical care for the population during an outbreak. Surgical delivery, owing to its cross-cutting nature and synergistic effects on health systems at large, needs to be built into the WHO agenda for national health planning.

Conclusion

Patients are being deprived of surgical access, with uncertain loss of function and risk of adverse prognosis as a collateral effect of the pandemic. Surgical services need a contingency plan for maintaining surgical care in an ongoing or postpandemic phase.

Graphical Abstract

Surgical services are adapting to mitigate the surge in patients with COVID-19 in need of critical care support. All non-essential elective surgery has been cancelled, or is pending cancellation, in healthcare systems around the globe, impacting millions of patients. The postpandemic phase will require re-establishment of surgical services, and capacity building to restore normalcy and to appropriately reduce the backlog of cases by priority. A framework for evaluation and a plan to incorporate surgical care into the WHO strategies for national health plans and pandemic mitigation is urgently needed.

Graphical Abstract.

Graphical Abstract

Preparing for the next wave

Introduction

The pandemic of COVID-19 caused by the coronavirus SARS-CoV-21 is disrupting global health, social welfare and the economy in a proportion unparalleled in modern history. In addition to the effects of the disease itself on public health, a collateral effect from near-universal disruption and cancellation of surgical services has emerged.

Although the seasonal disruption of surgical care and the occasional cancellation of surgery is not new to most healthcare systems2–4, the current pandemic has unprecedented implications for surgical services and patients with surgical conditions5. Surgical capacity may experience extreme challenges in war zones6,7, or in the case of mass casualty events from terror or during civilian accidents or natural disasters, with numbers exceeding the surgical capacity (such as operating theatres, number of surgeons and anaesthesia staff). In the current pandemic, rather than mobilizing surgical resources for surgical conditions in need, the current demand for ventilators, hospital space and personnel is depriving surgical capacity to a point where essential surgical delivery is strained in multiple regions, irrespective of their economic classification. This is having an immediate and long-term effect on millions of patients with surgical conditions worldwide. Globally, there have been deficits in surgical service preparation, delivery and recovery from the pandemic; lessons can be learned from countries in each phase of response.

Methods

An international collaborative of co-investigators representative of several surgical disciplines, geographical regions and with experience ranging from administrative leadership roles to frontline practice were involved. A detailed description of the search strategy, inclusion and exclusion criteria, and results are provided in Tables S1 and S2, Fig. S1 and AppendixS1 (supporting information). A scoping review approach was used8–10.

Impact of pandemic on surgical services

Based on the available reports and evolving real-time experience, the pandemic effects on surgery are profound, potentially long-lasting and extensive. Studies5,11–26 identified in relation to surgery and perioperative care comprised opinions, anecdotal reports and recommendations. Several national surgical societies had launched COVID-19-specific guidelines with dynamic updates, in addition to over 20 subdiscipline-specific surgical and perioperative guidelines (Table 1; Table S3, supporting information). Of particular note, information related to surgical services in a pandemic was scarce on the WHO website27.

Table 1.

Organizations providing perioperative guidelines for patients with COVID-19

Health systems guidelines Anaesthesia guidelines Surgical guidelines Subspecialty-specific guidelines
Centers for Disease Control and Prevention
European Centre for Disease Prevention and; Control
Government of Australia
United States Department of Defense
American Society of Anesthesiologists
Canadian Anesthesiologists' Society
Faculty of Intensive Care Medicine, Intensive Care Society, Association of Anaesthetists, and Royal College of Anaesthetists
Italian College of Anaesthesia, Analgesia, Resuscitation, and Intensive Care (SIAARTI)
South African Society of Anaesthesiologists
World Federation of Societies of Anaesthesiologists
American College of Surgeons
French Surgical Association
German Society of Surgery
Italian Society of Surgery (SIC) and Italian Association of Hospital Surgeons (ACOI)
Philippine College of Surgeons
Royal Australasian College of Surgeons
Royal College of Surgeons of England
Royal College of Surgeons of Ireland
Spanish Society of Surgery
Swedish Surgical Society
The Association of Surgeons of South Africa
The Pan African Association of Surgeons
American Academy of Ophthalmology
American Academy of Orthopedic Surgeons
American Academy of Otolaryngology
American Association of Oral and Maxillofacial Surgery
American Association for the Surgery of Trauma
American College of Obstetrics and Gynecology, Society for Maternal Fetal Medicine
American Dental Association
American Pediatric Surgical Association
American Society of Breast Surgeons
American Society for Gastrointestinal Endoscopy
American Society of Transplant Surgeons
American Urological Association
Americas Hepato-Pancreato-Biliary Association
Australian Society of Otolaryngology Head and Neck Surgery
British Association of Paediatric Surgeons
European Society of Surgical Oncology
German Society of General and Visceral Surgery
Philippine Association of HPB Surgeons
Royal College of Obstetricians and Gynaecologists
Sociedade Brasileira de Pneumologia e Tisiologia, Asociación Latinoamericana de Tórax
Sociedad Española de Neumología y Cirugía Torácica
Society of American Gastrointestinal and Endoscopic Surgeons & European Association for Endoscopic Surgery
Society of Surgical Oncology
Society of Thoracic Surgeons
Society for Vascular Surgery
World Society of Emergency Surgery

Societies with available COVID-19-specific information or recommendations on 10 April 2020. HPB, hepatopancreatobiliary.

Several generic themes are similar across regions, and may be used to mitigate the effects of the pandemic on surgical services, both in the short term and in the longer term, and to learn from for preparedness for future possible events.

From a public health perspective, the modelled response and effects are largely dependent on the slope of increase of diseased and critically ill patients, and how the peak of the pandemic curve evolves in order to cope with emerging needs (Fig. 1)28. The ability of surgical services to maintain a role depends on the peak of the pandemic, the spread of the disease, the duration of societal regulations, and the duration and temporal epidemic repeats by which the disease burden will approach the threshold of maximum capacity of the critical care resources (Fig. 1). Even in a situation where the threshold may not be exceeded, one may expect capacity to be close to, or temporarily breached, before the pandemic fades.

Fig. 1.

Pandemic burden and impact on surgical services

Fig. 1

The threshold for a given healthcare system may be broken by a surge in infected patients. Capacity to maintain even life-saving surgery may not be sustained (during major or minor peaks of outbreak), leading to a potential additional loss of lives unrelated to the pandemic disease itself, but as collateral damage. Mitigation or suppression strategies may be long-lasting (tail effect) and have effects on elective and semiurgent capacity, with the risk of worsening disease or function, or have a detrimental impact on prognosis. Models to show implications of the pandemic on various capacity scenarios are needed, as the toll on patients and public health is potentially enormous.

Addressing pandemic preparedness phase

In regions where hospital networks already exist, attempts at developing ‘COVID-19’ and ‘non-COVID-19’ hospitals may be a reasonable way to preserve surgical services and normal function, while containing the diseased population away from the non-diseased. Suggestions of how to manage this within and between hospitals have been proposed elsewhere29–31.

Reorganization of surgical services to hospitals and designated pathways

The success of pandemic preparedness and resilience of the system is largely dependent on the scale of the outbreak, the time frame and the pressure on health systems5,32. A hub-and-spoke model was used in the Lombardy region of Italy (AppendixS2, supporting information). However, this model may be feasible only until community transmission reaches a critical threshold.

At the institutional level, creating within-hospital pathways for ‘clean’ and ‘contaminated’ patient flow is essential to maintain open routes for regular diagnosis and treatment. Where resources allow, one should declare dedicated COVID-19 radiology units (CT scanners, etc.), wards, operating theatres and endoscopy suites. Such organization may imply having COVID-19-dedicated teams of healthcare professionals. Using separate pathways at the institutional level can also support rapid outbreaks where system-level ‘COVID-19’ and ‘non-COVID-19’ hospitals are not feasible, or when the pandemic reaches a state when hospital designation is no longer sustainable. However, a breakdown of barriers by hospital designation, by separated wards or clinical pathway designation should be prevented or mitigated to avoid uncontrolled spread of disease.

Designation of hospitals, care areas and healthcare professionals for COVID-19 care should be implemented early on to delay and prevent progression of the outbreak via healthcare institutions and professionals. Once the pandemic reaches a critical threshold through community transmission, these models may not be sustainable, and broader reorganization of care becomes necessary.

Reorganization of surgical services to critical care capacity

In the extreme case when waves of patients are admitted to hospital, the surge in critically ill patients may deprive surgical services of resources to the point of exclusion. Several regions have experienced this phenomenon and many are planning for this scenario, with cancellation of all non-essential surgery for an initial period33. Operating theatres and anaesthesia machines may be converted to temporary respiratory support units. Postoperative recovery rooms and intermediate-care units may be used as care units outside regular intensive care to manage sick patients with COVID-19. In this case, there is a real threat of disruption to all surgical services and difficulty maintaining even critical surgical care.

In order to prepare, all non-essential elective surgery has been recommended to be cancelled in many healthcare systems and by surgical societies, but with variable suggestions and advice across regions and disciplines (Table 1; Table S3, supporting information). Information and advice are changing as pressure, and needs rise and resources are stretched. New knowledge is emerging rapidly, leading to suggestions sometimes based on anecdotal reports at best. In general, deferral of surgery is especially recommended for non-urgent operations with a potential requirement for postoperative ICU care.

Reorganization of surgical workforce

In countries where intensive care medicine is part of, or integrated into, surgical care, there is an opportunity to relocate surgical providers to COVID-19 management to enhance the intensive care capacity of personnel familiar with, or experienced in, use of ventilators. Intensive care training is highly variable in surgical training across training systems, and actual practice and experience vary from country to country. In the USA and Canada, surgeons trained in critical care may be a resource for management of patients in need of respiratory support on a ventilator. In other regions, such as the Nordic countries, all intensive care is within the domain of anaesthetists trained in critical care. Thus, surgeons do not represent an immediate resource for allocation to such services. In addition, as anaesthetists will be involved in the critical care rota, their availability for surgical anaesthesia and perioperative care will be affected. Other forms of redirection of services are possible and needed in this setting.

Some surgeon subspecialists who do not usually cover emergency surgery (such as hepatobiliary surgeons and surgical oncologists) may be called on to cover emergency general surgery and trauma. As personnel may become diseased or quarantined, it may be necessary to rotate staff according to need and competence, and also to allow staff to have breaks from periods of extreme work pressure and intense workload.

Viral risks and effects on available workforce

With large numbers of staff being quarantined (owing to travel, contact or cluster exposure; for example, at risk, but not tested) or in imposed self-quarantine (sore throat, cough or cold; not tested) or who have actually contracted the disease (SARS-CoV-2-positive), there is also a need to relocate personnel across surgical services to cover staff shortages.

Appropriate personal protective equipment (PPE) is an absolute necessity, but has proven to be a global issue, with variable and unpredictable supply chains and delivery networks across the globe15. For the surgical workforce working on wards with non-infected patients, a high suspicion should be maintained and social distancing principles applied by patients and staff (such as working in smaller groups; splitting teams with alternating half-and-half working at home and on site; reducing participants in meetings; virtual participation at multidisciplinary team meetings through telecommunication)24,34–35.

Ambulatory surgery should stop, even if low risk, as this uses equipment and protective gear as well as having the risk of bilateral disease spread (patient to provider and vice versa). Reports of adverse effects and fatal outcomes from contracting COVID-19 after ambulatory and elective surgery are of concern14–15,25,36. Outpatient clinics should be reduced to a minimum, and maintained through alternative sources, such as video consultations. These have long been used in remote areas to avoid long travel distances34,37–39, but can be implemented rapidly even in large metropolitan regions to maintain social distancing during a pandemic35.

There are currently no data to assess the impact on the surgical (and related healthcare personnel) workforce. In Italy (AppendixS2, supporting information), several healthcare providers have developed severe COVID-19 and died. In Hong Kong (AppendixS3, supporting information) none of the healthcare workers have been infected by COVID-19 in the hospital setting. It is too early to predict the total impact on the healthcare workforce. A grave global concern is the universal lack of PPE, which is likely to have a huge impact on the morbidity and mortality of healthcare personnel from contracting COVID-19 owing to a lack of appropriate protection.

Reconsidering or redirection of choice of management

In a scenario in which the goal is to reduce unwanted admissions to hospital, to avoid surgery (if at all possible), or delay or defer interventions until resources or risk can be better controlled, there is a need to reconsider treatment options or management strategies for several disease groups. Surgeons are used to decision-making processes, albeit usually based on a broad array of clinical, personal and institutional variables40. A pandemic scenario changes the reasoning and premise by which decisions will be made. In general, a risk-averse strategy should be implemented. Notably, this may result in changes in management and outcomes for surgical conditions.

A template prescription of which patients should be preferred for a specific management option is not possible. Each patient should be evaluated individually. However, in a situation where resources are scarce, one should not treat or prioritize on a first-come, first-served principle41. Each healthcare system may have different principles by which decisions are guided. Ideally, decisions should not be based on local hospital directions. Where healthcare is delivered jurisdictionally, there should be governing principles organized regionally. Individually, healthcare workers should consult colleagues in teams to reach decisions in settings of priorities, end-of-life-decisions or when there is a need to rationalize resources41, in order to avoid fatigue, burn out, guilt and unbearable psychological pressures.

Surgical services during pandemic phase

Surgical care that is not essential or time-critical can be delayed and deferred to a later date when the pandemic subsides16. However, even in the midst of a pandemic certain procedure types must be performed, including appropriate cancer treatment, emergency surgery and urgent transplantation, as these are considered life-saving procedures with curative potential. A complete neglect of certain surgical services would be considered unwanted collateral damage, and inadvertently increase the number of deaths and life-years lost owing to the COVID-19 pandemic. This can create ethical dilemmas at a time of scarce resources and high pressure on critical care staff23,41–42, especially when surgical theatres are shut down or reduced to a minimum of activity, and triage for the indicated and urgent operations is required. Several surgical societies and organizations (Table 1; Table S3, supporting information) have launched lists of proposed procedures and ways of prioritizing these during times of high disease pressure.

Patients with conditions in need of high-priority elective or urgent surgery

There is no consensus on what types of non-elective, non-emergency procedures should proceed, and under what circumstances. The definition of elective surgery varies widely, but general recommendations have been issued by several surgical societies and organizations (Table 1) to advise on priorities and support cancellations or deferred procedures. A definition of major surgery is also lacking, and varies between surgeons, regions and even subdisciplines. A recent Delphi study43 agreed that ‘significant co-morbidities’ were the only preoperative factor retained to define major surgery. Notably, several of the risk factors in patients that predict risk of complications and need for intensive care after surgery are also the factors associated with higher risk of poor outcomes in COVID-19, including increasing age, diabetes, hypertension and cardiac disease44,45.

A conceptual framework might stratify medically necessary, time-sensitive surgery46 by variables that include the nature of the disease, the nature of the procedure and the nature of the patient. As regards procedures, variables to consider include the duration of operation, potential for ICU care, length of hospital stay, surgical site and risk of aerosolized droplets. Disease-specific considerations include the risk of delay on outcome (2, 4 or 8 weeks or longer) and alternative non-surgical options for therapy. Patient-specific considerations, in addition to COVID-19 or influenza-like illness status, might include age, pre-existing cardiopulmonary disease, immunocompetence and diabetes.

With some early reports of a high risk of postoperative morbidity and death in patients exposed to COVID-19 at the time of surgery14,36, a set of minimum screening initiatives should take place until better data are available. For patients with urgent and non-emergency surgical conditions requiring operation, before admission (or on admission in a pathway evaluation if admitted semiurgently) there should be an interview with attention to sick contacts and extent of social isolation performed. A single swab with PCR or chest CT on the day before surgery to screen for COVID-19 is recommended by some47,48. The applicability of these measures may change as knowledge, testing capability and sensitivity evolve, and with prevalence of COVID-19 (and evolving immunity) among the public.

Considering risk of surgery during COVID-19 pandemic

Patients with COVID-19 present with the classical symptoms of fever, dry cough and difficulty breathing44,49–51, but it is increasingly being recognized that a large number of patients have minimal or no symptoms in the early course of the disease. Digestive symptoms may have been overlooked in early reports, as increasing numbers of patients are being reported to have abdominal symptoms52–55. An increasing number of reports are suggesting that other symptoms may be associated with COVID-19, such as anosmia56,57. A thorough history of risk and exposure as well as testing should be done for all patients admitted for elective surgery.

The SARS-CoV-2 virus is particularly contagious through transmission via droplets. Airborne transmission via aerosols remains uncertain, debated and of concern. Hence, the premise for delivering essential diagnostic and therapeutic interventions for surgical conditions has already changed. Evaluation of mitigation strategies and risk is needed in order to unlock current changes to practice. The implications of transmission risk uncertainty may last months, if not years, for the practice of surgery.

Outcomes after surgery in COVID-19 have not yet been investigated systematically, but anecdotal experience reports unfavourable outcomes even after some routine surgical operations (such as cholecystectomy, hernia repair and hysterectomy)14,36. The effects of COVID-19 on surgery (and vice versa) are not known. Pathological changes in blood coagulation58, inflammatory response59, and co-morbidities added to single or multiple organ failures60 may be considered as mechanisms for added risk for surgery.

As a general recommendation, surgery on patients who are SARS-CoV-2-positive or have symptomatic COVID-19 should be undertaken only in true emergency circumstances. For patients in the ICU who develop a surgical condition, surgery should be considered when discussed as a likely life-saving intervention with benefit to the patient. Non-surgical or minimally invasive alternatives should be entertained, if possible, such as draining a severely infected gallbladder rather than operating.

Surgery for patients with COVID-19 should be performed in designated theatres, preferably located in the periphery of other theatres, and with negative-pressure room ventilation11,13,17–18. Procedure for transport of patients with COVID-19 should be followed strictly – either from ward or from ICU to theatres61. If the patient is not already intubated, precautions for intubation should be adhered to, as this is considered to be a procedure with high aerosol risk12,17,62. Perioperative guidelines (Table 1) must be consulted, as these are evolving based on new knowledge11–13.

Emergency general surgery admissions

Patients who are admitted for an acute abdomen (and in need of surgery) may be co-infected with COVID-19, and hence represent a risk for contamination of healthcare personnel and other patients, even when not feeling ill or experiencing severe symptoms suggestive of COVID-19.

With an increasing number of infected yet asymptomatic subjects in the population, a high clinical suspicion for non-typical symptoms is also warranted. Notably, several hospitals have started to include CT of the thorax as a routine part of diagnostic evaluation (and COVID-19 screening) if cross-sectional imaging of the abdomen is part of the planned work-up, as there have been several anecdotal reports of diagnosis of typical lung findings in patients without respiratory symptoms or other signs suggestive of COVID-19. Typically, ground-glass findings may be present in the early phase of the disease course63. Only after finding the CT signs, and testing the patients using regular swabs, was the disease actually confirmed as SARS-CoV-2. This poses a particular challenge to the healthcare system to avoid potentially admitting and treating patients with otherwise no suspect symptoms.

Trauma admissions still occur during a pandemic, although there are unconfirmed reports of a reduction in acute and trauma admissions as an effect of the social distancing and overall reduced activity in society. Although trauma admissions may drop, so may recruitment of the regular pool of blood donors, potentially leading to a shortage of blood products in some systems. In addition, coagulation may be affected in patients who are COVID-19-positive, potentially adding to issues with bleeding injuries58. As reported in Seattle, Washington, in the early phase of the outbreak64, the overall use of blood products decreased significantly among inpatients and remained stable in the outpatient clinic at the starting point. However, owing to the confinement situation taking place in some countries, blood reserves could be affected as donations decrease. Although coronavirus predominantly infects the respiratory tract, the potential risk of transmission by transfusion needs to be addressed. One of the main concerns is the ability asymptomatic patients may have to infect during the incubation period65. Appropriate testing of donors who give blood during the pandemic should be put in place.

Transplant activity

Organ transplantation is a life-saving procedure. Limiting access to transplantation is associated with a significant loss of prognosis for most patients on the transplant list. How the pandemic affects organ transplantation is related to impact on the donor pool, risk of transmission of infection, risk to living donors and overall access to scarce resources66,67. Donors must be tested and confirmed as COVID-19-negative. The risk of bloodborne transmission during transplantation appears to be low, as only about 1–15 per cent of subjects appear to have circulating virus RNA50. Lung transplantation poses a particular problem.

In planning the reorganization of transplant programmes during the pandemic, a phased approach scaled to the current severity of the pandemic has been suggested. Accordingly, most centres have initially stopped elective living donor programmes while maintaining other transplant services66–68. The scenario of submitting a healthy donor to a major surgical procedure concomitant with the risk of being infected with COVID-19 must be considered and calls for caution, even if cases of successful recovery exist69. Furthermore, the competition for scarce resources related to hospital and ICU beds and blood transfusions mandates strict prioritization. As the overall strain of the pandemic intensifies, this might dynamically change organ allocation and prioritization policies66–68.

In times of crisis and shortage of resources, several ethical challenges may present23–24,42. The competing risks and need to allocate resources may require a change in patient priorities in several surgical disciplines, notably transplantation, cancer surgery and other high-risk procedures. As a result, some patients may unfortunately not be offered the treatment they would otherwise have received.

Preparing surgical services for postpandemic phase

The cancellation of all elective operations creates a huge backlog of patients who have been, or would be, seen for planned surgery (Fig. 2). With a long-lasting lockdown and social distancing in effect, there will be millions of operations cancelled, deferred or simply not done at all over the coming months. Surgery is already recognized as a scarce resource in much of the world70–72, with a global challenge to provide safe surgery and anaesthesia as a recognized area of priority73.

Fig. 2.

Proposed framework for surgical planning through pandemic phases

Fig. 2

The framework is a basic overview of steps for surgical services to incorporate, and is not exhaustive. Currently, no universal framework for planning of surgical services and maintenance of capacity exists in the governing organizations. Surgery may be affected disproportionally by the loss of space and personnel, and the uncertainty of associated risks to patients and with exposure to procedures, compared with other disciplines. Training and simulation for personnel (donning and doffing; getting used to specific personal protective equipment (PPE); logistics and transport) is important in every phase. Clear and continued communication of information and knowledge is of the essence in all phases. *Depending on burden to hospital/region.

Although the majority of infected people experience a mild disease, there are currently only anecdotal reports on potential adverse outcomes even after relatively minor, elective surgical procedures14,36. Until better data are at hand, the uncertainty will affect management during the surge of the pandemic and also have implications in the long term during the ‘tail’ of the pandemic (Fig. 1), as COVID-19 may be present in the general population for months ahead (until vaccine is universally available), until proper systems for high-accuracy testing and availability allow proper protection of patients and healthcare providers alike.

There is a lack of data on the actual risk of several procedures that are potentially aerosol-generating, including thoracoscopic interventions, laparoscopic abdominal surgery, endoscopic procedures, and open surgery performed with traditional equipment (including electrocautery and tissue-sealing devices)14,26,74. Safety hazards need to be addressed and investigated by proper methods to arrive at guidelines that protect surgical teams appropriately15,16. Changing clinical practice to a point that jeopardizes surgical care or even leads to substandard management in fear of COVID-19 should be avoided.

Rebuilding surgical capacity after pandemic

There is no existing knowledge as to what impact this loss of surgical capacity will have on patients' surgical condition and associated health, or in terms of well-being, functional capacity, risk of loss of function or adverse effects on prognosis. It is known from cancellations under normal circumstances that patients can experience feelings of sadness, disappointment, anger, frustration and stress75. This comes in addition to the potential economic consequence (loss of work, sick leave or inability to maintain occupancy) and impact on family life.

There are currently no robust data available to model the number of operations being put on hold and how this backlog will be addressed in the aftermath of the pandemic. However, rough estimates suggest that approximately 330 million operations are done worldwide annually76, the vast majority in high-income regions now exercising a strong policy of cancellation of all non-essential surgery (North America and European countries). With a global average of about six million procedures per week, the aggregated numbers of patients who will be affected over the coming months are growing at a concerning pace. Little is known about the timeline or duration of these cancellations, or what criteria should be used to reopen these services.

In the current pandemic, patients may prefer to have non-essential elective surgery deferred owing to fear of contracting the disease while in hospital. However, this fear may also lead patients not to seek timely care for conditions that would otherwise have been correctable or curable by presenting at an earlier stage; loss of function and reduced life expectancy may be the result of delayed presentation and an untimely diagnosis. This burden will only increase with the duration and severity of the pandemic.

Future research and need for better knowledge

The current situation is unparalleled in modern history, and so no readily available information exists to compare or project the effect of disruption of surgical services on public health during the pandemic. Medical resources and response systems must be evaluated after this pandemic in order to prepare for the next2.

Data on the effects of surgical cancellation on patient well-being, including emotional and physical health, are much needed. In addition, the effect of the backlog of operations and the aftermath of the pandemic will need to be analysed. As elective surgery has been cancelled on a scale never before seen in modern history, the collateral damage to health and well-being, maintenance of function, and risk of shortened lifespan is present for patients in countries of all income designations. However, the implicit assumption is that the poor and marginalized will be affected most severely. For this reason, an equity-based approach to critical analysis will provide answers that could guide future health system strengthening that works toward a socially just construction of surgical systems.

Finally, we call for a structured framework for evaluation of this COVID-19 pandemic vis à vis surgical care delivery. It is imperative to understand how and why different countries were prepared (or not), how the effects of the pandemic on surgical services were mitigated, and how some countries managed the delivery of surgical care in their healthcare services better than others. A strong advocacy agenda is needed that includes investigation, planning, research and communication for surgical and anaesthesia services for future pandemics. Surgical delivery before, during and after a pandemic, owing to its cross-cutting nature and synergistic effects on health systems at large, needs to be built into the WHO agenda for national health planning. We must ask the questions that will lead to appropriate change in how countries should construct surgical systems in terms of infrastructure, workforce, care delivery, information management, financing and governance to prepare for future events on this scale.

Supplementary Material

bjs11670-sup-0001-Supinfo

Appendix S1. Supporting Information

Acknowledgements

The authors thank several colleagues who shared their experience during times of extreme workload and pressure in the pandemic epicentres. The views expressed are those of the authors and not necessarily those of any organization or society.

Disclosure: The authors declare no conflict of interest.

References

  • 1. Wu Y, Ho W, Huang Y, Jin DY, Li S, Liu SLet al. SARS-CoV-2 is an appropriate name for the new coronavirus. Lancet 2020; 395: 949–950. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2. Argo JL, Vick CC, Graham LA, Itani KM, Bishop MJ, Hawn MT. Elective surgical case cancellation in the Veterans Health Administration system: identifying areas for improvement. Am J Surg 2009; 198: 600–606. [DOI] [PubMed] [Google Scholar]
  • 3. Cookson G, Jones S, Laliotis I. Cancelled procedures in the English NHS: evidence from the 2010 tariff reform. Health Econ 2017; 26: e126–e139. [DOI] [PubMed] [Google Scholar]
  • 4. Al Talalwah N, McIltrot KH. Cancellation of surgeries: integrative review. J Perianesth Nurs 2019; 34: 86–96. [DOI] [PubMed] [Google Scholar]
  • 5. Spinelli A, Pellino G. COVID-19 pandemic: perspectives on an unfolding crisis. Br J Surg 2020; 10.1002/bjs.11627 [Epub ahead of print]. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6. Ali HH, Lamsali H, Othman SN. Operating rooms scheduling for elective surgeries in a hospital affected by war-related incidents. J Med Syst 2019; 43: 139. [DOI] [PubMed] [Google Scholar]
  • 7. Bar-El Y, Reisner S, Beyar R. Moral dilemmas faced by hospitals in time of war: the Rambam Medical Center during the second Lebanon war. Med Health Care Philos 2014; 17: 155–160. [DOI] [PubMed] [Google Scholar]
  • 8. Munn Z, Peters MDJ, Stern C, Tufanaru C, McArthur A, Aromataris E. Systematic review or scoping review? Guidance for authors when choosing between a systematic or scoping review approach. BMC Med Res Methodol 2018; 18: 143. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9. Peters MD, Godfrey CM, Khalil H, McInerney P, Parker D, Soares CB. Guidance for conducting systematic scoping reviews. Int J Evid Based Healthc 2015; 13: 141–146. [DOI] [PubMed] [Google Scholar]
  • 10. Colquhoun HL, Levac D, O'Brien KK, Straus S, Tricco AC, Perrier Let al. Scoping reviews: time for clarity in definition, methods, and reporting. J Clin Epidemiol 2014; 67: 1291–1294. [DOI] [PubMed] [Google Scholar]
  • 11. Dexter F, Parra MC, Brown JR, Loftus RW. Perioperative COVID-19 defense: an evidence-based approach for optimization of infection control and operating room management. Anesth Analg 2020; 10.1213/ANE.0000000000004829 [Epub ahead of print]. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12. Greenland JR, Michelow MD, Wang L, London MJ. COVID-19 infection: implications for perioperative and critical care physicians. Anesthesiology 2020; 10.1097/ALN.0000000000003303 [Epub ahead of print]. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13. Chen X, Liu Y, Gong Y, Guo X, Zuo M, Li Jet al. ; Chinese Society of Anesthesiology, Chinese Association of Anesthesiologists. Perioperative management of patients infected with the novel coronavirus: recommendation from the Joint Task Force of the Chinese Society of Anesthesiology and the Chinese Association of Anesthesiologists. Anesthesiology 2020; 10.1097/ALN.0000000000003301 [Epub ahead of print]. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14. Aminian A, Safari S, Razeghian-Jahromi A, Ghorbani M, Delaney CP. COVID-19 outbreak and surgical practice: unexpected fatality in perioperative period. Ann Surg 2020; 10.1097/SLA.0000000000003925 [Epub ahead of print]. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15. Brat GA, Hersey SP, Chhabra K, Gupta A, Scott J. Protecting surgical teams during the COVID-19 outbreak: a narrative review and clinical considerations. Ann Surg 2020; (in press). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16. Brindle M, Gawande A. Managing COVID-19 in surgical systems. Ann Surg 2020; 10.1097/SLA.0000000000003923 [Epub ahead of print]. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17. Ti LK, Ang LS, Foong TW, Ng BSW. What we do when a COVID-19 patient needs an operation: operating room preparation and guidance. Can J Anaesth 2020; 10.1007/s12630-020-01617-4 [Epub ahead of print]. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18. Wong J, Goh QY, Tan Z, Lie SA, Tay YC, Ng SYet al. Preparing for a COVID-19 pandemic: a review of operating room outbreak response measures in a large tertiary hospital in Singapore. Can J Anaesth 2020; 10.1007/s12630-020-01620-9 [Epub ahead of print]. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19. Qin J, Wang H, Qin X, Zhang P, Zhu L, Cai Jet al. Perioperative presentation of COVID-19 disease in a liver transplant recipient. Hepatology 2020; 10.1002/hep.31257 [Epub ahead of print]. [DOI] [PubMed] [Google Scholar]
  • 20. Zhao S, Ling K, Yan H, Zhong L, Peng X, Yao Set al. Anesthetic management of patients with COVID 19 infections during emergency procedures. J Cardiothorac Vasc Anesth 2020; 34: 1125–1131. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21. Chan JYK, Wong EWY, Lam W. Practical aspects of otolaryngologic clinical services during the 2019 novel coronavirus epidemic: an experience in Hong Kong. JAMA Otolaryngol Head Neck Surg 2020; 10.1001/jamaoto.2020.0488 [Epub ahead of print]. [DOI] [PubMed] [Google Scholar]
  • 22. COVIDSurg Collaborative . Global guidance for surgical care during the COVID-19 pandemic. Br J Surg 2020; (in press). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23. Ives J, Huxtable R. Surgical ethics during a pandemic: moving into the unknown? Br J Surg 2020; 10.1002/bjs.11638 [Epub ahead of print]. [DOI] [PubMed] [Google Scholar]
  • 24. Vogler SA, Lightner AL. Rethinking how we care for our patients in a time of social distancing. Br J Surg 2020; 10.1002/bjs.11636 [Epub ahead of print]. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25. Di Marzo F, Sartelli M, Cennamo R, Toccafondi G, Coccolini F, La Torre Get al. Recommendations for general surgery activities in a pandemic scenario (SARS-CoV-2). Br J Surg 2020; (in press). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26. Mowbray NG, Ansell J, Horwood J, Cornish J, Rizkallah P, Parker Aet al. Safe management of surgical smoke in the age of COVID-19. Br J Surg 2020; (in press). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27. WHO . Coronavirus Disease (COVID-19) Technical Guidance: Maintaining Essential Health Services and Systems. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/maintaining-essential-health-services-and-systems [accessed 31 March 2020]. [Google Scholar]
  • 28. Hellewell J, Abbott S, Gimma A, Bosse NI, Jarvis CI, Russell TWet al. Feasibility of controlling COVID-19 outbreaks by isolation of cases and contacts. Lancet Glob Health 2020; 8: e488–e496. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29. Chopra V, Toner E, Waldhorn R, Washer L. How should U.S. hospitals prepare for coronavirus disease 2019 (COVID-19)? Ann Intern Med 2020; 10.7326/M20-0907 [Epub ahead of print]. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30. Hu XH, Niu WB, Zhang JF, Li BK, Yu B, Zhang ZYet al. [Thinking of treatment strategies for colorectal cancer patients in tumor hospitals under the background of coronavirus pneumonia.] Zhonghua Wei Chang Wai Ke Za Zhi 2020; 23: 10.3760/cma.j.cn441530-20200217-00058 [Epub ahead of print]. [DOI] [PubMed] [Google Scholar]
  • 31. Zhu W, Wang Y, Xiao K, Zhang H, Tian Y, Clifford SPet al. Establishing and managing a temporary coronavirus disease 2019 specialty hospital in Wuhan, China. Anesthesiology 2020; 10.1097/ALN.0000000000003299 [Epub ahead of print]. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32. Gagliano A, Villani PG, Co FM, Paglia S, Bisagni PAG, Perotti GMet al. COVID-19 epidemic in the middle province of northern Italy: impact, logistics, and strategy in the first line hospital. Disaster Med Public Health Prep 2020: 1–5. 10.1017/dmp.2020.51 [Epub ahead of print]. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33. Iacobucci G. Covid-19: all non-urgent elective surgery is suspended for at least three months in England. BMJ 2020; 368: m1106. [DOI] [PubMed] [Google Scholar]
  • 34. Augestad KM, Sneve AM, Lindsetmo RO. Telemedicine in postoperative follow-up of STOMa PAtients: a randomized clinical trial (the STOMPA trial). Br J Surg 2020; 107: 509–518. [DOI] [PubMed] [Google Scholar]
  • 35. Hollander JE, Carr BG. Virtually perfect? Telemedicine for Covid-19. N Engl J Med 2020; 10.1056/NEJMp2003539 [Epub ahead of print]. [DOI] [PubMed] [Google Scholar]
  • 36. Lei S, Jiang F, Su W, Chen C, Chen J, Mei Wet al. Clinical characteristics and outcomes of patients undergoing surgeries during the incubation period of COVID-19 infection. EClinicalMedicine 2020: 100331. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37. Buvik A, Bugge E, Knutsen G, Småbrekke A, Wilsgaard T. Quality of care for remote orthopaedic consultations using telemedicine: a randomised controlled trial. BMC Health Serv Res 2016; 16: 483. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38. Zanaboni P, Wootton R. Adoption of routine telemedicine in Norwegian hospitals: progress over 5 years. BMC Health Serv Res 2016; 16: 496. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39. Buvik A, Bergmo TS, Bugge E, Smaabrekke A, Wilsgaard T, Olsen JA. Cost-effectiveness of telemedicine in remote orthopedic consultations: randomized controlled trial. J Med Internet Res 2019; 21: e11330. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40. Kulkarni SS, Briggs A, Sacks OA, Rosengart MR, White DB, Barnato AEet al. Inner deliberations of surgeons treating critically-ill emergency general surgery patients: a qualitative analysis. Ann Surg 2019; 10.1097/SLA.0000000000003669 [Epub ahead of print]. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41. Emanuel EJ, Persad G, Upshur R, Thome B, Parker M, Glickman Aet al. Fair allocation of scarce medical resources in the time of Covid-19. N Engl J Med 2020; 10.1056/NEJMsb2005114 [Epub ahead of print]. [DOI] [PubMed] [Google Scholar]
  • 42. Rosenbaum L. Facing Covid-19 in Italy – ethics, logistics, and therapeutics on the epidemic's front line. N Engl J Med 2020; 10.1056/NEJMp2005492 [Epub ahead of print]. [DOI] [PubMed] [Google Scholar]
  • 43. Martin D, Mantziari S, Demartines N, Hübner; ESA Study Group Collaborators . Defining major surgery: a Delphi consensus among European Surgical Association (ESA) members. World J Surg 2020; 10.1007/s00268-020-05476-4 [Epub ahead of print]. [DOI] [PubMed] [Google Scholar]
  • 44. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Zet al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020; 395: 1054–1062. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45. Wu C, Chen X, Cai Y, Xia J, Zhou X, Xu Set al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med 2020. 10.1001/jamainternmed.2020.0994 [Epub ahead of print]. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46. Prachand VN, Milner R, Angelos P, Posner MC, Fung JJ, Agrawal Net al. Medically-necessary, time-sensitive procedures: a scoring system to ethically and efficiently manage resource scarcity and provider risk during the COVID-19 pandemic; J Am Coll Surg 2020. 10.1016/j.jamcollsurg.2020.04.011 [Epub ahead of print]. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47. Ai T, Yang Z, Hou H, Zhan C, Chen C, Lv Wet al. Correlation of chest CT and RT–PCR testing in coronavirus disease 2019 (COVID-19) in China: a report of 1014 cases. Radiology 2020; 10.1148/radiol.2020200642 [Epub ahead of print]. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48. Fang Y, Zhang H, Xie J, Lin M, Ying L, Pang Pet al. Sensitivity of chest CT for COVID-19: comparison to RT–PCR. Radiology 2020; 10.1148/radiol.2020200432 [Epub ahead of print]. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49. Young BE, Ong SWX, Kalimuddin S, Low JG, Tan SY, Loh Jet al. ; Singapore 2019 Novel Coronovirus Outbreak Research Team. Epidemiologic features and clinical course of patients infected with SARS-CoV-2 in Singapore. JAMA 2020; 10.1001/jama.2020.3204 [Epub ahead of print]. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Yet al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020; 395: 497–506. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51. Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JXet al. ; China Medical Treatment Expert Group for Covid-19. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 2020; 10.1056/NEJMoa2002032 [Epub ahead of print]. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52. Luo S, Zhang X, Xu H. Don't overlook digestive symptoms in patients with 2019 novel coronavirus disease (COVID-19). Clin Gastroenterol Hepatol 2020; 10.1016/j.cgh.2020.03.043 [Epub ahead of print]. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53. Wong SH, Lui RN, Sung JJ. Covid-19 and the digestive system. J Gastroenterol Hepatol 2020; 10.1111/jgh.15047 [Epub ahead of print]. [DOI] [PubMed] [Google Scholar]
  • 54. Liang W, Feng Z, Rao S, Xiao C, Xue X, Lin Zet al. Diarrhoea may be underestimated: a missing link in 2019 novel coronavirus. Gut 2020: gutjnl-2020-320832; 10.1136/gutjnl-2020-320832 [Epub ahead of print]. [DOI] [PubMed] [Google Scholar]
  • 55. Zhou Z, Zhao N, Shu Y, Han S, Chen B, Shu X. Effect of gastrointestinal symptoms on patients infected with COVID-19. Gastroenterology 2020; 10.1053/j.gastro.2020.03.020 [Epub ahead of print]. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56. Mao L, Wang M, Chen S, He Q, Chang J, Hong Cet al. Neurological manifestations of hospitalized patients with COVID-19 in Wuhan, China: a retrospective case series study. medRxiv 2020. [Google Scholar]
  • 57. Bagheri SHR, Asghari AM, Farhadi M, Shamshiri AR, Kabir A, Kamrava SKet al. Coincidence of COVID-19 epidemic and olfactory dysfunction outbreak. medRxiv 2020. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58. Han H, Yang L, Liu R, Liu F, Wu KL, Li Jet al. Prominent changes in blood coagulation of patients with SARS-CoV-2 infection. Clin Chem Lab Med 2020; 10.1515/cclm-2020-0188 [Epub ahead of print]. [DOI] [PubMed] [Google Scholar]
  • 59. Qin C, Zhou L, Hu Z, Zhang S, Yang S, Tao Yet al. Dysregulation of immune response in patients with COVID-19 in Wuhan, China. Clin Infect Dis 2020. 10.1093/cid/ciaa248 [Epub ahead of print]. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60. Wang T, Du Z, Zhu F, Cao Z, An Y, Gao Yet al. Comorbidities and multi-organ injuries in the treatment of COVID-19. Lancet 2020; 395: e52. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61. Liew MF, Siow WT, Yau YW, See KC. Safe patient transport for COVID-19. Crit Care 2020; 24: 94. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62. Wujtewicz M, Dylczyk-Sommer A, Aszkielowicz A, Zdanowski S, Piwowarczyk S, Owczuk R. COVID-19 – what should anaethesiologists and intensivists know about it? Anaesthesiol Intensive Ther 2020; 52: 34–41. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63. Rodriguez-Morales AJ, Cardona-Ospina JA, Gutiérrez-Ocampo E, Villamizar-Peña R, Holguin-Rivera Y, Escalera-Antezana JPet al. ; Latin American Network of Coronavirus Disease 2019-COVID-19 Research (LANCOVID-19). Clinical, laboratory and imaging features of COVID-19: a systematic review and meta-analysis. Travel Med Infect Dis 2020; 10.1016/j.tmaid.2020.101623 [Epub ahead of print]. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64. Pagano MB, Hess JR, Tsang HC, Staley E, Gernsheimer T, Sen Net al. Prepare to adapt: blood supply and transfusion support during the first 2 weeks of the 2019 novel coronavirus (COVID-19) pandemic affecting Washington State. Transfusion 2020; 10.1111/trf.15789 [Epub ahead of print]. [DOI] [PubMed] [Google Scholar]
  • 65. Chang L, Yan Y, Wang L. Coronavirus disease 2019: coronaviruses and blood safety. Transfus Med Rev 2020; 10.1016/j.tmrv.2020.02.003 [Epub ahead of print]. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66. Kumar D, Manuel O, Natori Y, Egawa H, Grossi P, Han SHet al. COVID-19: a global transplant perspective on successfully navigating a pandemic. Am J Transplant 2020; 10.1111/ajt.15876 [Epub ahead of print]. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67. Michaels MG, La Hoz RM, Danziger-Isakov L, Blumberg EA, Kumar D, Green Met al. Coronavirus disease 2019: implications of emerging infections for transplantation. Am J Transplant 2020; 10.1111/ajt.15832 [Epub ahead of print]. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68. Gori A, Dondossola D, Antonelli B, Mangioni D, Alagna L, Reggiani Pet al. Coronavirus disease 2019 and transplantation: a view from the inside. Am J Transplant 2020; 10.1111/ajt.15853 [Epub ahead of print]. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69. Zhu L, Xu X, Ma K, Yang J, Guan H, Chen Set al. Successful recovery of COVID-19 pneumonia in a renal transplant recipient with long-term immunosuppression. Am J Transplant 2020; 10.1111/ajt.15869 [Epub ahead of print]. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 70. Holmer H, Bekele A, Hagander L, Harrison EM, Kamali P, Ng-Kamstra JSet al. Evaluating the collection, comparability and findings of six global surgery indicators. Br J Surg 2019; 106: e138–e150. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 71. McDermott FD, Kelly ME, Warwick A, Arulampalam T, Brooks AJ, Gaarder Tet al. Problems and solutions in delivering global surgery in the 21st century. Br J Surg 2016; 103: 165–169. [DOI] [PubMed] [Google Scholar]
  • 72. Søreide K, Winter DC. Global surgery in an ecosystem for worldwide health. Br J Surg 2019; 106: e12–e13. [DOI] [PubMed] [Google Scholar]
  • 73. Roa L, Jumbam DT, Makasa E, Meara JG. Global surgery and the sustainable development goals. Br J Surg 2019; 106: e44–e52. [DOI] [PubMed] [Google Scholar]
  • 74. Zheng MH, Boni L, Fingerhut A. Minimally invasive surgery and the novel coronavirus outbreak – lessons learned in China and Italy. Ann Surg 2020; 10.1097/SLA.0000000000003924 [Epub ahead of print]. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 75. Herrod PJJ, Adiamah A, Boyd-Carson H, Daliya P, El-Sharkawy AM, Sarmah PBet al. ; WES-Pi Study Group on behalf of the East Midlands Surgical Academic Network (EMSAN); WES-Pi Study Group . Winter cancellations of elective surgical procedures in the UK: a questionnaire survey of patients on the economic and psychological impact. BMJ Open 2019; 9: e028753. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 76. Weiser TG, Haynes AB, Molina G, Lipsitz SR, Esquivel MM, Uribe-Leitz Tet al. Size and distribution of the global volume of surgery in 2012. Bull World Health Organ 2016; 94: 201F–209F. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

bjs11670-sup-0001-Supinfo

Appendix S1. Supporting Information


Articles from The British Journal of Surgery are provided here courtesy of Oxford University Press

RESOURCES